Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.

Cancers (Basel) · 2026 · PMC13162621 · PMID 42122175

Europe PMC DOI

hedged sentence

0.2270

closest p · 4.5× alpha

0.2270

boldest claim

The sentences

did not reach statistical significancep = 0.227not close (p > 0.1)

27.52%; p = 0.009), while diabetes was numerically more frequent but did not reach statistical significance ( p = 0.227).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.